Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis.

Area of Science:

• Lipid metabolism research
• Inflammatory disease biomarkers
• Sarcoidosis pathophysiology

Background:

• Active sarcoidosis is associated with reduced high-density lipoprotein (HDL) cholesterol levels.
• The specific role of serum amyloid A (SAA) in this lipid disorder requires further investigation.

Purpose of the Study:

• To analyze the association between serum amyloid A (SAA) levels and lipid abnormalities in sarcoidosis.
• To investigate the potential role of SAA in the pathogenesis of low HDL-cholesterol in active sarcoidosis.

Main Methods:

• Recruited 85 untreated sarcoid patients (40 active, 45 inactive).
• Assessed sarcoidosis activity using clinical, radiological, and biochemical markers.
• Measured serum lipid profiles, apolipoproteins (A-I, B), SAA, and LCAT activity.

Main Results:

• Active sarcoidosis showed significantly lower HDL-cholesterol and apolipoprotein A-I, and higher triglycerides and apolipoprotein B compared to inactive disease.
• Serum amyloid A (SAA) levels were significantly elevated in active sarcoidosis patients.
• Multivariate analysis revealed HDL-cholesterol and SAA as independent predictors of sarcoidosis activity, with SAA negatively correlating with HDL-cholesterol and apolipoprotein A-I in active disease.

Conclusions:

• Elevated SAA levels in active sarcoidosis are linked to decreased HDL-cholesterol and apolipoprotein A-I.
• SAA may displace apolipoprotein A-I from HDL particles, explaining the reduced HDL-cholesterol observed in active sarcoidosis.